(Press-News.org) Contact information: Nuria Noriega
comunicacion@cnio.es
Centro Nacional de Investigaciones Oncologicas (CNIO)
CNIO researchers propose a new combined therapy to treat cancer
The combination of etoposide with compounds that interfere with the cell cycle could increase specificity and improve the therapeutic window for cancer treatments
A large part of the effort dedicated to cancer research is directed towards the search for combinations of existing drugs—many of which have already been introduced into clinical practice—that permit higher overall survival rates and improvements in the quality of life of cancer patients.
Marcos Malumbres, a researcher at the Spanish National Cancer Research Centre (CNIO), and his team have discovered how etoposide — a drug widely used in the treatment of lung and testicular cancers, leukaemias and brain tumours — could increase its efficiency and specificity in combination with other compounds that interfere with cell division. The results are published today in the journal Cell Reports.
The study has been carried out jointly with the Groups of Óscar Fernández-Capetillo and Javier Muñoz's at the CNIO, and with Hiroyuki Yamano's team at the University College London's Cancer Institute.
Etoposide, a compound obtained from a variant of the mandrake plant, blocks a protein needed for DNA repair during cell division: the Topoisomerase II (TOP2) enzyme. This blocking action increases the damage to genetic material and causes cell death.
Malumbres explains that: "Etoposide affects tumour cells, which are the ones that divide the most and that need TOP2 to repair their DNA, but it also affects healthy cells", adding that: "this lack of specificity causes alterations in healthy tissues that translate into secondary illnesses and toxicity for the organism".
The researchers point out that "the challenge now is to improve the drug's therapeutic window, so that the dose range becomes more effective without increasing toxicity and the secondary effects associated with the treatment".
TREATMENTS TARGETING TUMOUR CELLS
Up until now, data on molecular pathways that govern topoisomerase levels in cells were scarce and did not clarify much. Now, Manuel Eguren, a researcher on Malumbres's team, has, for the first time in animal models and in human cell lines, related TOP2 with the cell division protein regulator Cdh1, so that a decrease in Cdh1 activity increases TOP2 levels in cells.
This study allows for the identification of the formula for increasing TOP2 levels in cells. The research team therefore proposes a new form of effective tumour treatment: the combination of Cdh1 inhibitors (amongst which can be found a substance called proTAME) with etoposide.
"proTAME — which is undergoing preclinical trials to inhibit tumour cell division — could increase the effectiveness of etoposide in cancer cells, those that divide the most and those that therefore have a greater dependency on TOP2 to maintain DNA integrity", say the researchers. This combination of drugs could maximise the anti-neoplastic effect of etoposide and would imply a reduction in the dose and lower toxicity.
Previous studies further indicate that Cdh1 is inactive in some patients due to various oncogenic mutations. "Our data suggest that patient stratification based on their tumour´s Cdh1 status could improve the effect of etoposide in these patients' treatment".
The next step for Malumbres' team is to study this new drug cocktail in patients and to investigate the tumours in which this new therapeutic strategy would be most effective.
INFORMATION:
This project has been funded by the Ministry of Economy and competitiveness, the European Union and the Community of Madrid.
CNIO researchers propose a new combined therapy to treat cancer
The combination of etoposide with compounds that interfere with the cell cycle could increase specificity and improve the therapeutic window for cancer treatments
2014-02-06
ELSE PRESS RELEASES FROM THIS DATE:
U of T report finds millions of Canadians still struggle to afford food
2014-02-06
Four million Canadians, including 1.15 million children, are living in households where it is sometimes a struggle to put food on the table, according to researchers at the University ...
Fires in Victoria, Australia, Feb. 6, 2014
2014-02-06
Fires in and around Snowy River National Park in Victoria, Australia were captured by the Moderate Resolution Imaging Spectroradiometer (MODIS) aboard the Aqua satellite on February 06, 2014. Actively burning areas, detected ...
A microchip for metastasis
2014-02-06
Nearly 70 percent of patients with advanced breast cancer experience skeletal metastasis, in which cancer cells migrate from a primary ...
Fires in Northern Sumatra
2014-02-06
Fires dot the coast of Northern Sumatra, Indonesia, in this Moderate Resolution Imaging Spectroradiometer (MODIS) satellite image collected on February 06, 2014. The MODIS instrument is aboard the Terra satellite and actively burning ...
RNA sequencing of 750-year-old barley virus sheds new light on the Crusades
2014-02-06
Scientists have for the first time sequenced an ancient RNA genome – of a barley virus once believed to be only 150 years old - pushing its origin back at least 2,000 years and revealing how intense ...
Vanderbilt scientists contribute to finding that could lead to the first effective RSV vaccine
2014-02-06
Vanderbilt University scientists have contributed to a major finding, reported today in the journal Nature, which could lead to the first effective ...
NASA sees Tropical Cyclone Edilson leaving Mauritius
2014-02-06
NASA's Terra satellite saw Tropical Cyclone Edilson pulling away from the island of Mauritius in the Southern Indian Ocean when it passed overhead on February 6, 2014.
The Moderate Resolution Imaging Spectroradiometer ...
Heart health through gut health
2014-02-06
A new study, "Effect of probiotics on biomarkers of cardiovascular disease: implications for heart-healthy diets," published in the January issue of Nutrition ...
New investigational drug holds promise for combatting deadly mucormycosis infections
2014-02-06
LOS ANGELES – (Feb. 6, 2014) – With very few treatment options available ...
Quick test finds signs of diarrheal disease
2014-02-06
Bioengineers at Rice University and the University of Texas Medical Branch (UTMB) at Galveston have developed a simple, highly sensitive and efficient test for the diarrheal disease ...
LAST 30 PRESS RELEASES:
Sulfated yeast rises to the challenge facing rare earth metals
Global analysis reveals how biochar supercharges composting and cuts greenhouse gases
Blocking a cellular switch could prevent lung-scarring disease
Planet formation depends on when it happens: UNLV model shows why
Deep sleep supports memory via brain fluid and neural rhythms
Biochar and iron additives show promise for reviving degraded peatlands and locking away carbon
Cancer cells reactivate embryo-like gene editors to fuel growth
AI analysis of world’s largest heart attack datasets opens way to new treatment strategies
Decoding dangers of Arctic sea ice with seismic, radar method
Counting bites with AI might one day help prevent childhood obesity
Utah chemists discover enzyme that could help build next-generation GLP-1 drugs
Surprising bacteria discovery links Hawaiʻi’s groundwater to the ocean
New grants for schools offer CPR training and resources to make campuses safer
30 NFL players urge fans to join Nation of Lifesavers, learn lifesaving CPR
Study finds humans outweigh climate in depleting Arizona's water supply
Old-school material could power quantum computing, cut data center energy use
Vanderbilt scientist tackles key roadblock for AI in drug discovery
Overheating bat boxes place bats in mortal danger during heatwaves
Study shows medical-legal partnerships aid recovery for patients with violent injuries
Learning the language of lasso peptides to improve peptide engineering
Social conflict among strongest predictors of teen mental health concerns
New framework can improve the planning stage of surgical quality improvement projects
Research shows anger, not fear, shifts political beliefs
Gale and Ira Drukier Prize in Children’s Health Research awarded to pediatric rheumatologist at Boston Children’s Hospital
UNF chemistry professor awarded NSF Grant to advance laser-based measurement technology
Research shows how Dust Bowl-type drought causes unprecedented productivity loss
Non-hibernating pikas' protein restriction tweaks their gut microbiome to help them survive the winter, when winter-active herbivores often struggle to find dietary protein
Not for hearing but for symbiosis
Disconnected cerebral hemisphere in epilepsy patients shows sleep-like state during wakefulness
Incentivizing risk to inspire investments in clean innovation for aviation
[Press-News.org] CNIO researchers propose a new combined therapy to treat cancerThe combination of etoposide with compounds that interfere with the cell cycle could increase specificity and improve the therapeutic window for cancer treatments